{{Rsnum
|rsid=10069748
|Gene=ELL2
|Chromosome=5
|position=95905518
|Orientation=plus
|GMAF=0.4132
|Gene_s=ELL2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 7.1 | 38.9 | 54.0
| HCB | 26.3 | 46.0 | 27.7
| JPT | 9.7 | 49.6 | 40.7
| YRI | 41.5 | 46.3 | 12.2
| ASW | 40.4 | 49.1 | 10.5
| CHB | 26.3 | 46.0 | 27.7
| CHD | 22.2 | 43.5 | 34.3
| GIH | 22.8 | 52.5 | 24.8
| LWK | 38.2 | 48.2 | 13.6
| MEX | 10.3 | 37.9 | 51.7
| MKK | 41.7 | 46.2 | 12.2
| TSI | 8.8 | 44.1 | 47.1
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23382691
  |Trait=IgG glycosylation
  |Title=Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.
  |RiskAllele=C
  |Pval=5E-6
  |OR=.15
  |ORtxt=[0.088-0.22] unit decrease
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}